Trials / Conditions / Intestinal Neoplasms

Intestinal Neoplasms

25 registered clinical trials studyying Intestinal Neoplasms — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy NCT07222800	Pfizer	Phase 3
Recruiting	SGM-101 in Colorectal Brain Metastases. NCT04755920	Leiden University Medical Center	Phase 2
Unknown	Application of IPC During Surgery to Prevent Venous Thrombosis in Gastrointestinal Surgery Patients. NCT06260150	Feng Tian	N/A
Completed	A Prospective, Multicenter Randomized Controlled Study of the Application of Preoperative FOLFOXIRI Chemothera NCT06048146	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	N/A
Active Not Recruiting	CRC Detection Reliable Assessment With Blood NCT05551052	New Day Diagnostics	—
Unknown	Camrelizumab Combined With Trastuzumab and Chemotherapy in Patients With HER2-positive Advanced Colorectal Can NCT05193292	Fudan University	Phase 2
Terminated	A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic NCT04644315	Hoffmann-La Roche	Phase 2
Recruiting	Spanish Series of Patients Treated With the Radionuclide Lutetium177 NCT04949282	Sociedad Española de Medicina Nuclear e Imagen Molecular	—
Completed	Changes in Coagulation in Colorectal Cancer Patients Undergoing Surgical Treatment NCT04744688	University of Aarhus	—
Completed	Usefulness of GI-GENIUS in FIT-based Colorectal Cancer Screening Program. NCT04673136	Asociación Española de Gastroenterología	N/A
Unknown	Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Un NCT05322486	State Scientific Centre of Coloproctology, Russian Federation	—
Completed	Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients NCT04080843	Zhejiang University	Phase 2
Completed	Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma NCT03559543	Catalysis SL	Phase 2
Unknown	Study of Small Bowel Tumor With Dual-phase Enhanced Computed Tomography (CTE) and Magnetic Resonance Enterogra NCT03659357	Tongji Hospital	—
Unknown	Apatinib Versus Bevacizumab in Second-line Therapy for Colorectal Cancer(ABST-C) NCT03271255	Shenzhen People's Hospital	Phase 2
Completed	Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Can NCT03037385	Hoffmann-La Roche	Phase 1 / Phase 2
Unknown	NEOadjuvant Chemotherapy Only Compared With Standard Treatment for Locally Advanced Rectal Cancer NCT03280407	Zealand University Hospital	Phase 2
Completed	BowelScope: Accuracy of Detection Using ENdocuff Optimisation of Mucosal Abnormalities NCT03072472	South Tyneside and Sunderland NHS Foundation Trust	N/A
Completed	Endorings™ Assisted Colonoscopy Versus Standard Colonoscopy for Polyp Detection NCT02785783	Portsmouth Hospitals NHS Trust	N/A
Unknown	Adoptive Cell Therapy Plus Chemotherapy and Radiation After Surgery in Treating Patients With Colorectal Cance NCT02202928	Shenzhen Hornetcorn Bio-technology Company, LTD	Phase 2
Completed	A Phase III Study of 2nd-line XELIRI ± Bevacizumab vs. FOLFIRI ± Bevacizumab in mCRC NCT01996306	Epidemiological and Clinical Research Information Network	Phase 3
Unknown	Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous In NCT01995942	Royal Marsden NHS Foundation Trust	—
Unknown	A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRC NCT03303495	Sun Yat-sen University	Phase 3
Unknown	Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks NCT01037049	Royal Marsden NHS Foundation Trust	Phase 2
Unknown	Low Rectal Cancer Study (MERCURY II) NCT02005965	Royal Marsden NHS Foundation Trust	—